A multicenter prospective randomized study to assess the prophylactic efficacy of postoperative single intravesical instillation with pirarubicin and mitomycin C for low-risk non-muscle-invasive bladder cancer
Latest Information Update: 08 Sep 2020
At a glance
- Drugs Pirarubicin (Primary) ; Mitomycin
- Indications Bladder cancer; Carcinoma; Urogenital cancer
- Focus Therapeutic Use
- 08 Sep 2020 New trial record
- 01 Sep 2020 Primary endpoint (Recurrence-free survival) has been met, according to results published in the Anticancer Research
- 01 Sep 2020 Results published in the Anticancer Research